Pathological Factors Affecting DNA Quality in BRAF, EGFR, and KRAS Gene Molecular Tests
![]() |
Yun, Hyon-Goo
(Department of Pathology, Kangbuk Samsung Hospital)
Kim, Bo-Ra (Department of Pathology, Kangbuk Samsung Hospital) Lee, Joo-Mi (Department of Pathology, Kangbuk Samsung Hospital) Song, Eun-Ha (Department of Pathology, Kangbuk Samsung Hospital) Kim, Dong-Hoon (Department of Pathology, Kangbuk Samsung Hospital) |
1 | Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjo A, Rouleau E, et.al. Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol. 2014;67:923-931. https://doi.org/10.1136/jclinpath-2014-202404 DOI |
2 | Hunt JL. Molecular pathology in anatomic pathology practice: a review of basic principles. Arch Pathol Lab Med. 2008; 132:248-260. https://doi.org/10.1043/1543-2165(2008)132[248:MPIAPP]2.0.CO;2 DOI |
3 | Carithers LJ, Agarwal R, Guan P, Odeh H, Sachs MC, Engel KB, et al. The biospecimen preanalytical variables program: a multiassay comparison of effects of delay to fixation and fixation duration on nucleic acid quality. Arch Pathol Lab Med. 2019; 143:1106-1118. https://doi.org/10.5858/arpa.2018-0172-OA DOI |
4 | Yun HG, Lee HJ, Kim BR, Lee JH, Lee JH, Kim K, et.al. Factors affecting KRAS mutation detection in colorectal cancer tissue. Pathol Res Pract. 2019;215:1071-1075. https://doi.org/10.1016/j.prp.2019.02.018. DOI |
5 | Zhao J, Liu P, Yu Y, Zhi J, Zheng X, Yu J, et al. Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer. Oncol Lett. 2019;17:4661-4666. https://doi.org/10.3892/ol.2019.10131 DOI |
6 | Yatabe Y, Kerr KM, Utomo A, Rajadurai P, Tran VK, Du X, et al. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol. 2015;10:438-445. https://doi.org/10.1097/JTO.0000000000000422 DOI |
7 | Shackelford RE, Whitling NA, McNab P, Japa S, Coppola D. KRAS testing: a tool for the implementation of personalized medicine. Genes Cancer. 2012;3:459-466. https://doi.org/10.1177/1947601912460547 DOI |
8 | Prentice LM, Miller RR, Knaggs J, Mazloomian A, Aguirre Hernandez R, Franchini P, et al. Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice. PLoS One. 2018;13:e0196434. https://doi.org/10.1371/journal.pone.0196434 DOI |
9 | Taguchi M, Inoue H, Motani-Saitoh H, Yajima D, Hayakawa M, Otsuka K, et al. DNA identification of formalin-fixed organs is affected by fixation time and type of fixatives: using the AmpF l STR(R) Identifiler(R) PCR amplification kit. Med Sci Law. 2012;52:12-16. https://doi.org/10.1258/msl.2011.010140 DOI |
10 | Dudley JC, Gurda GT, Tseng LH, Anderson DA, Chen G, Taube JM, et al. Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma. Mol Diagn Ther. 2014;18:409-418. https://doi.org/10.1007/s40291-014-0091-6 DOI |
![]() |